Focus on Clinical Trials
New Research Disrupts Cancer's Feeding Cycle
March 11, 2013
Study Evaluates Newer Treatment for Women Whose Breast Cancer Has Spread
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.
January 07, 2013
Popular Pain Relievers and Bladder Cancer
November 05, 2012
From Bench to Bedside and Back Again
October 11, 2011





